|
|
|
Insider
Information: |
Bvf Inc/il |
Relationship: |
Indirect Beneficial Ow... |
City: |
|
State: |
|
|
|
Insider
Summary: |
|
|
|
Companies Owned : |
12 |
|
Direct
Shares |
49,829,941 |
|
Indirect Shares
|
136,880,248 |
|
|
Direct
Value |
$2,550,278,644 |
|
|
Indirect Value
|
$7,642,993,607 |
|
|
Total
Shares |
186,710,189 |
|
|
Total
Value |
$10,193,272,250 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
Total
Filings :
|
19
|
2
|
Stock
price went up :
|
18
|
0
|
Stock
price went down : |
1
|
2
|
|
|
|
Gain/Loss Ratio : |
18.0
|
-2.0
|
Percentage
Gain/Loss : |
64.8%
|
-200.0%
|
|
|
|
|
|
|
Holdings
:
Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold |
|
Neurocrine Biosciences Inc |
NBIX |
10% Owner |
2010-04-12 |
5,041,447 |
2010-04-12 |
15,124,341 |
Premium* |
|
NPS Pharmaceuticals Inc |
NPSP |
Indirect Beneficial Ow... |
2008-03-11 |
0 |
2008-09-22 |
4,383,115 |
Premium* |
|
Astex Pharmaceuticals Inc |
ASTX |
Indirect Beneficial Ow... |
2008-05-01 |
0 |
2008-05-09 |
5,753,399 |
Premium* |
|
Neurobiological Technologies Inc |
NTII |
10% Owner |
2009-10-21 |
331,998 |
2009-10-21 |
995,994 |
Premium* |
|
Epirus Biopharmaceuticals Inc |
EPRS |
10% Owner |
2009-12-22 |
6,830,972 |
2009-12-22 |
20,492,916 |
Premium* |
|
Capstone Therapeutics Corp |
CAPS |
Indirect Beneficial Ow... |
2008-10-10 |
0 |
2008-10-14 |
5,136,888 |
Premium* |
|
Adolor Corp |
ADLR |
Indirect Beneficial Ow... |
2008-10-10 |
4,428,032 |
2008-10-31 |
6,214,551 |
Premium* |
|
Dynavax Technologies Corp |
DVAX |
10% Owner |
2009-09-10 |
4,278,851 |
2009-09-10 |
12,836,553 |
Premium* |
|
Ligand Pharmaceuticals Inc |
LGND |
Indirect Beneficial Ow... |
2009-07-01 |
15,169,950 |
2009-07-01 |
45,509,850 |
Premium* |
|
Curis Inc |
CRIS |
Indirect Beneficial Ow... |
2009-02-03 |
8,921,716 |
2009-04-27 |
5,951,716 |
Premium* |
|
Repligen Corp |
RGEN |
Indirect Beneficial Ow... |
2009-07-07 |
2,765,050 |
2009-07-07 |
8,295,150 |
Premium* |
|
Gyre Therapeutics |
GYRE |
Indirect Beneficial Ow... |
2009-10-16 |
2,061,925 |
2009-10-16 |
6,185,775 |
Premium* |
|
|
|
|
|
|
|
|
|
|
Records found :
195 |
Free Registration Required For Full Results. Limit: 25
|
|
Download |
Page 6 of 8
|
Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
LGND |
Ligand Pharmaceuticals In... |
Indirect Beneficial Owner |
|
2008-11-17 |
4 |
B |
$1.33 |
$122,323 |
I/I |
92,000 |
10,663,309 |
1.5 |
- |
|
LGND |
Ligand Pharmaceuticals In... |
Indirect Beneficial Owner |
|
2008-11-18 |
4 |
B |
$1.38 |
$112,536 |
I/I |
81,400 |
10,744,709 |
1.5 |
- |
|
LGND |
Ligand Pharmaceuticals In... |
Indirect Beneficial Owner |
|
2008-11-19 |
4 |
B |
$1.39 |
$45,906 |
I/I |
33,000 |
10,777,709 |
1.5 |
- |
|
ARQL |
Arqule Inc |
Indirect Beneficial Owner |
|
2008-11-19 |
4 |
B |
$2.65 |
$780,194 |
I/I |
294,413 |
11,903,173 |
1.5 |
- |
|
LGND |
Ligand Pharmaceuticals In... |
Indirect Beneficial Owner |
|
2008-11-20 |
4 |
B |
$1.26 |
$11,631 |
I/I |
9,200 |
10,786,909 |
1.5 |
- |
|
EPRS |
Epirus Biopharmaceuticals... |
Indirect Beneficial Owner |
|
2008-11-21 |
4 |
B |
$0.45 |
$5,400 |
I/I |
12,000 |
8,315,999 |
1.5 |
- |
|
ARQL |
Arqule Inc |
Indirect Beneficial Owner |
|
2008-11-21 |
4 |
B |
$2.40 |
$816,524 |
I/I |
340,900 |
12,244,073 |
1.5 |
- |
|
LGND |
Ligand Pharmaceuticals In... |
Indirect Beneficial Owner |
|
2008-11-21 |
4 |
B |
$1.78 |
$331,751 |
I/I |
186,744 |
10,973,653 |
1.5 |
- |
|
NBIX |
Neurocrine Biosciences In... |
Indirect Beneficial Owner |
|
2008-11-24 |
4 |
B |
$2.45 |
$133,258 |
I/I |
54,400 |
5,713,047 |
1.5 |
- |
|
LGND |
Ligand Pharmaceuticals In... |
Indirect Beneficial Owner |
|
2008-11-24 |
4 |
B |
$2.01 |
$287,573 |
I/I |
143,000 |
11,116,653 |
1.5 |
- |
|
EPRS |
Epirus Biopharmaceuticals... |
Indirect Beneficial Owner |
|
2008-11-24 |
4 |
B |
$0.45 |
$37,395 |
I/I |
83,100 |
8,399,099 |
1.5 |
- |
|
LGND |
Ligand Pharmaceuticals In... |
Indirect Beneficial Owner |
|
2008-11-25 |
4 |
B |
$1.77 |
$625,481 |
I/I |
353,000 |
11,469,653 |
1.5 |
- |
|
EPRS |
Epirus Biopharmaceuticals... |
Indirect Beneficial Owner |
|
2008-11-25 |
4 |
B |
$0.47 |
$5,754 |
I/I |
12,300 |
8,411,399 |
1.5 |
- |
|
EPRS |
Epirus Biopharmaceuticals... |
Indirect Beneficial Owner |
|
2008-11-26 |
4 |
B |
$0.49 |
$3,260 |
I/I |
6,600 |
8,417,999 |
1.42 |
- |
|
LGND |
Ligand Pharmaceuticals In... |
Indirect Beneficial Owner |
|
2008-11-26 |
4 |
B |
$1.93 |
$2,622,922 |
I/I |
1,350,000 |
12,819,653 |
1.5 |
- |
|
LGND |
Ligand Pharmaceuticals In... |
Indirect Beneficial Owner |
|
2008-11-28 |
4 |
B |
$1.99 |
$479,612 |
I/I |
240,600 |
13,060,253 |
1.5 |
- |
|
LGND |
Ligand Pharmaceuticals In... |
Indirect Beneficial Owner |
|
2008-12-01 |
4 |
B |
$1.86 |
$245,476 |
I/I |
131,700 |
13,191,953 |
1.5 |
- |
|
EPRS |
Epirus Biopharmaceuticals... |
Indirect Beneficial Owner |
|
2008-12-01 |
4 |
B |
$0.55 |
$14,740 |
I/I |
26,800 |
8,444,799 |
1.5 |
- |
|
NBIX |
Neurocrine Biosciences In... |
Indirect Beneficial Owner |
|
2008-12-01 |
4 |
B |
$2.35 |
$233,173 |
I/I |
99,400 |
5,812,447 |
1.5 |
- |
|
EPRS |
Epirus Biopharmaceuticals... |
Indirect Beneficial Owner |
|
2008-12-02 |
4 |
B |
$0.55 |
$5,356 |
I/I |
9,800 |
8,454,599 |
1.5 |
- |
|
LGND |
Ligand Pharmaceuticals In... |
Indirect Beneficial Owner |
|
2008-12-02 |
4 |
B |
$1.90 |
$365,928 |
I/I |
193,000 |
13,384,953 |
1.5 |
- |
|
EPRS |
Epirus Biopharmaceuticals... |
Indirect Beneficial Owner |
|
2008-12-03 |
4 |
B |
$0.54 |
$7,216 |
I/I |
13,400 |
8,467,999 |
1.5 |
- |
|
LGND |
Ligand Pharmaceuticals In... |
Indirect Beneficial Owner |
|
2008-12-03 |
4 |
B |
$1.95 |
$54,080 |
I/I |
27,739 |
13,412,692 |
1.5 |
- |
|
LGND |
Ligand Pharmaceuticals In... |
Indirect Beneficial Owner |
|
2008-12-04 |
4 |
B |
$2.04 |
$196,057 |
I/I |
96,300 |
13,508,992 |
1.5 |
- |
|
EPRS |
Epirus Biopharmaceuticals... |
Indirect Beneficial Owner |
|
2008-12-04 |
4 |
B |
$0.55 |
$5,665 |
I/I |
10,300 |
8,478,299 |
1.5 |
- |
|
195 Records found
|
|
Page 6 of 8 |
|
Free Registration Required For Full Results. Limit: 25
|
|
|
Transaction Code Key: |
Ownership Code Key |
|
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
|
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
|
IO |
- Initital Ownership |
D |
- Disposed |
|
|
|
|
|
|